marketinsights

Revolutionizing Regenerative Medicine: H-CYTE Successfully Acquires Skindisc Tissue Kit from Scion Solutions LLC

H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scio Wound Healing and Limb Salvage Technology Added to Growing Asset Portfolio Company’s Second Completed Transaction in Four Months TAMPA, Fla., Dec. 29, 2022 (GLOBE NEWSWIRE) — H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that the Company completed its acquisition of SkinDisc™. H-CYTE,…

Read More

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger!

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger! New York, NY, Dec. 27, 2022 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII”), www.gtii-us.com, and Creatd, Inc. (CRTD: OTCQB) (“Creatd”), today announced that they have formally begun discussions to explore synergies, including a potential merger….

Read More

Attention Investors: Lawsuit Filed Against Silvergate Capital Corporation – Contact Bragar Eagel & Squire, P.C. for More Info!

Welcome to the Silvergate Capital Corporation Class Action Lawsuit Alert! What’s Going On? So, you may have heard about the recent class action lawsuit filed against Silvergate Capital Corporation. If not, let me give you the lowdown. Bragar Eagel & Squire, P.C., a well-known stockholder rights law firm, has taken legal action against Silvergate in…

Read More

LM Funding America Inc. Chairman and CEO to Make Guest Appearance on Bloomberg Radio’s ‘Bloomberg Businessweek’ at 3:20 PM EST

Welcome to LM Funding America Blog! Breaking News: Chairman and CEO to Appear on Bloomberg Radio TAMPA, FL, Dec. 23, 2022 (GLOBE NEWSWIRE) – LM Funding America, Inc. (NASDAQ:LMFA) LM Funding America, Inc. (LMFA), a cryptocurrency mining and technology-based specialty finance company, is thrilled to announce that the Company’s Chairman and CEO, Bruce Rodgers, will…

Read More

Breaking News: Intercept Reapplies for FDA Approval of Obeticholic Acid for Liver Fibrosis in NASH Patients

Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis NDA supported by robust NASH clinical development program Two positive interim analyses from the Phase 3 REGENERATE study NDA includes detailed safety analysis of 2,477 patients with nearly 1,000 patients on study drug for 4 years MORRISTOWN, N.J., Dec….

Read More

Discover the Latest Distributions from PIMCO Canada Corp: Monthly and Annual Updates for PIMCO Canada Exchange-Traded Series

Embracing Change: PIMCO Canada Corp. Announces Monthly and Annual Distributions A New Chapter Begins Change is inevitable in life, and when it comes to financial matters, adapting to change is essential for growth and success. PIMCO Canada Corp. has recently announced the December and annual cash distributions for the ETF series of the PIMCO Canada…

Read More